http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013123411-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2013-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937d10e3eb23b6336dbef8b8ca64b64a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d06281160ed3ccf9574bf747b6d3523
publicationDate 2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013123411-A1
titleOfInvention Methods for diagnosing and treating cancer
abstract Methods for the diagnosis and treatment of cancer are provided. In certain aspects, overexpression of KDM2A (also referred to as FBXLl 1 or JHDMIA) is associated with a poor prognosis in certain cancers, such as non-small cell lung cancer (NSCLC). Methods of predicting response to KDM2A inhibitor therapies are also provided. Inhibitors of KDM2A may be used in various aspects to treat a cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10189787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107406414-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9802941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9221801-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111562379-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111004848-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107406414-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111004848-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111562379-B
priorityDate 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203057-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410453

Total number of triples: 38.